Rachel Cotton

T1D Fund thesis

Supporting The Next Generation Of T1D Treatments The T1D Fund is uniquely positioned to transform the T1D therapeutic landscape through impact investment We invest in opportunities that reduce developmental risk, accelerate progress, and generate returns—all of which are reinvested into the Fund to fuel future investments in breakthrough T1D treatments (neither management nor donors receive distributions). Given the Fund is an affiliate of Breakthrough T1D, a 501(c)(3) organization, all donor contributions raised for the Fund are recorded as charitable donations where donors receive tax benefi

Sector and stage focus

• Series A: Health IT, Health & Hospital Services
• general: Boston / New England
• Seed: Health IT, Health & Hospital Services

Is Rachel Cotton a fit for your round?

Upload your pitch deck and see whether Rachel Cotton appears in your top 20 matches.